m-TOR inhibitors and their potential role in haematological malignancies
Author:
Affiliation:
1. Unit of Lymphoid Malignancies; Department of Onco-Haematology; IRCCS San Raffaele Scientific Institute; Milano Italy
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14529/fullpdf
Reference117 articles.
1. PI 3-kinase related kinases: ‘big’ players in stress-induced signaling pathways;Abraham;DNA Repair (Amst),2004
2. PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma;Abubaker;Leukemia,2007
3. Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma;Albiges;Annals of Oncology,2012
4. Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107);Amadori;British Journal of Haematology,2012
5. Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group;Ansell;Cancer,2008
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genome-wide CRISPR screening identifies critical role of phosphatase and tensin homologous (PTEN) in sensitivity of acute myeloid leukemia to chemotherapy;Journal of Zhejiang University-SCIENCE B;2024-08
2. Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells;Blood Neoplasia;2024-06
3. A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia;Cancer Medicine;2023-11-13
4. Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitor;Leukemia;2023-08-02
5. Mammalian target of rapamycin (mTOR) inhibitors in dermatology;Indian Journal of Dermatology, Venereology and Leprology;2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3